ALG-000184 (pevifoscorvir sodium) monotherapy in participants with chronic HBV infection: a phase 1, multicentre, randomised, dose escalation trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-05-14 16:53:19 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2468-1253(25)00293-6
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2468125325002936
其他信息:
出版社: Elsevier BV
作者: Man-Fung Yuen; Kosh Agarwal; Alina Jucov; Jinlin Hou; Junqi Niu; Yanhua Ding; Alexei Haceatrean; Xie'er Liang; Jia Xu; Min Wu; Kha Le; Tse-I Lin; Lawrence Blatt; Sushmita Chanda; John Fry; Ed Gane

